Pasithea Therapeutics (KTTAW) Stock Chart & Stock Price History $0.02 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Pasithea Therapeutics Stock Price Performance The Pasithea Therapeutics (KTTAW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 10.67%, with a year-to-date return of -54.05%. In the past month, the stock has decreased 20.10%, reflecting recent market activity. As of the latest close, Pasithea Therapeutics traded at $0.02 with a market cap of and volume of 2,000 shares. Receive KTTAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.67%1 Month Performance-20.10%3 Month Performance-20.50%Year-To-Date Performance-54.05%1 Year PerformanceN/A KTTAW Stock Chart for Saturday, July, 12, 2025 KTTAW Chart by TradingView Pasithea Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$0.02$0.02$0.02$0.022,000 shs$0.0007/10/2025$0.02$0.02-12.86%$0.02$0.022,000 shs$0.0007/09/2025$0.02$0.02$0.02$0.021,000 shs$0.0007/08/2025$0.02$0.02+17.98%$0.02$0.021,000 shs$0.0007/07/2025$0.02$0.02+17.11%$0.02$0.02223 shs$0.0007/04/2025$0.02$0.02$0.03$0.027,200 shs$0.0007/03/2025$0.02$0.02-3.80%$0.03$0.027,200 shs$0.0007/02/2025$0.02$0.02+1.28%$0.03$0.027,200 shs$0.0007/01/2025$0.02$0.02-10.34%$0.02$0.021,600 shs$0.0006/30/2025$0.02$0.02-19.44%$0.02$0.0219,500 shs$0.00 Get the Latest News and Ratings for KTTAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$0.02$0.02$0.02$0.0219,500 shs$0.0006/26/2025$0.02$0.02-1.63%$0.02$0.0219,584 shs$0.0006/25/2025$0.02$0.02+20.26%$0.02$0.0219,584 shs$0.0006/24/2025$0.02$0.02-23.88%$0.02$0.027,933 shs$0.0006/23/2025$0.02$0.02+5.24%$0.02$0.02700 shs$0.0006/20/2025$0.02$0.02$0.02$0.02732 shs$0.0006/19/2025$0.02$0.02$0.02$0.02100 shs$0.0006/18/2025$0.02$0.02+3.24%$0.02$0.02100 shs$0.0006/17/2025$0.02$0.02+3.35%$0.02$0.02392 shs$0.0006/16/2025$0.02$0.02+12.58%$0.02$0.027,200 shs$0.0006/13/2025$0.02$0.02-20.10%$0.02$0.027,205 shs$0.0006/12/2025$0.02$0.02+22.09%$0.02$0.02400 shs$0.0006/11/2025$0.02$0.02$0.02$0.02800 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart Ampio Pharmaceuticals Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Biofrontera Stock Price Chart biote Stock Price Chart BriaCell Therapeutics Stock Price Chart Receive KTTAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KTTAW) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KTTAW Stock Alerts